To evaluate PharmaShell in depot formulation of monoclonal antibody Not a new field for Nanexa: already generated promising mAb data" />
To evaluate PharmaShell in depot formulation of monoclonal antibody Not a new field for Nanexa: already generated promising mAb data" />
To evaluate PharmaShell in depot formulation of monoclonal antibody Not a new field for Nanexa: already generated promising mAb data" />
Nanexa: New evaluation agreement in mAb space - ABG
Nanexa: New evaluation agreement in mAb space - ABG
Signs evaluation agreement with "large global pharma company" To evaluate PharmaShell in depot formulation of monoclonal antibody Not a new field for Nanexa: already generated promising mAb data
ANNONS
New evaluation agreement with large global pharma company
Nanexa has announced today that it has signed a new Material Transfer and Feasibility Study Agreement agreement with a large global pharmaceutical company (company undisclosed). The agreement is to evaluate PharmaShell in a depot formulation of a monoclonal antibody.
